+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Futura Medical Plc (FUM) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 45 Pages
  • June 2023
  • GlobalData
  • ID: 1315567
Futura Medical Plc (FUM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Futura Medical Plc (Futura Medical) is a pharmaceutical company that develops products based on its transdermal DermaSys drug delivery technology. It focuses on therapeutic areas including pain relief and sexual health. The company’s lead products in the pipeline include MED3000, a topical gel for erectile dysfunction (ED) and TPR100 gel for pain relief. Its other products include CBD100 topical cannabidiol formulation for pain relief. The company carries out development operations through its wholly owned subsidiary Futura Medical Developments Limited. Futura Medical is headquartered in Surrey, the UK.

Futura Medical Plc Key Recent Developments

  • Apr 05, 2023: Futura Medical : Full Year Results for the year ended 31 December 2022
  • Mar 27, 2023: Futura Medical PLC Notice of Preliminary Results 2022
  • Sep 13, 2022: Futura Medical announces interim results for the six months ended 30 June 2022
  • Aug 31, 2022: Highly positive FM71 phase 3 study results with all primary and secondary endpoints achieved, MED3000 remains on track to obtain US FDA marketing authorisation

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Futura Medical Plc - Key Facts
  • Futura Medical Plc - Key Employees
  • Futura Medical Plc - Key Employee Biographies
  • Futura Medical Plc - Major Products and Services
  • Futura Medical Plc - History
  • Futura Medical Plc - Company Statement
  • Futura Medical Plc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Futura Medical Plc - Business Description
  • R&D Overview
  • Futura Medical Plc - Corporate Strategy
  • Futura Medical Plc - SWOT Analysis
  • SWOT Analysis - Overview
  • Futura Medical Plc - Strengths
  • Futura Medical Plc - Weaknesses
  • Futura Medical Plc - Opportunities
  • Futura Medical Plc - Threats
  • Futura Medical Plc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Futura Medical Plc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Futura Medical Plc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Futura Medical Plc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Apr 05, 2023: Futura Medical : Full Year Results for the year ended 31 December 2022
  • Mar 27, 2023: Futura Medical PLC Notice of Preliminary Results 2022
  • Sep 13, 2022: Futura Medical announces interim results for the six months ended 30 June 2022
  • Aug 31, 2022: Highly positive FM71 phase 3 study results with all primary and secondary endpoints achieved, MED3000 remains on track to obtain US FDA marketing authorisation
  • Apr 26, 2022: Futura Medical announces full year results for the year ended 31 December 2021
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Futura Medical Plc, Key Facts
  • Futura Medical Plc, Key Employees
  • Futura Medical Plc, Key Employee Biographies
  • Futura Medical Plc, Major Products and Services
  • Futura Medical Plc, History
  • Futura Medical Plc, Subsidiaries
  • Futura Medical Plc, Key Competitors
  • Futura Medical Plc, Ratios based on current share price
  • Futura Medical Plc, Annual Ratios
  • Futura Medical Plc, Interim Ratios
  • Futura Medical Plc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Futura Medical Plc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Futura Medical Plc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Futura Medical Plc, Performance Chart (2018 - 2022)
  • Futura Medical Plc, Ratio Charts
  • Futura Medical Plc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Futura Medical Plc, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

Samples

Loading
LOADING...

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Medherant Ltd
  • Antev Ltd
  • Neurocentrx Pharma Ltd
  • Avanos Medical UK Limited
  • Vernalis R&D Ltd